Angiotensin receptor blockers and risk of prostate cancer among United States veterans

• Published in: Journal of clinical pharmacology Vol. 53; no. 7; p. 773
• Main Authors: Rao, Gowtham A, Mann, Joshua R, Bottai, Matteo, Uemura, Hiroji, Burch, James B, Bennett, Charles Lee, Haddock, Kathlyn Sue, Hébert, James R
• Format: Journal Article
• Language: English
• Published: England 01.07.2013
• Subjects: Aged; Angiotensin Receptor Antagonists - administration & dosage; Angiotensin Receptor Antagonists - adverse effects; Cohort Studies; Humans; Male; Middle Aged; Prostatic Neoplasms - chemically induced; Prostatic Neoplasms - epidemiology; Retrospective Studies; Risk; United States - epidemiology; Veterans - statistics & numerical data; United States

To address concerns regarding increased risk of prostate cancer (PrCA) among angiotensin receptor blocker (ARB) users, we used national retrospective data from the Department of Veterans Affairs (VA) through the Veterans Affairs Informatics and Computing Infrastructure. We identified a total of 543,...